What's new

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 16, Status: Authorised

Apr 11, 2025 - 14:09
 0
Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Cosmogen gets its sustainability commitments certified

Next Article

Sofitel Hotels to open in Porto, Portugal in 2028

Related Posts

Orphan designation: bexmarilimab Treatment of myelodysplastic syndromes, 25/03/2025 Positive

Orphan designation: bexmarilimab Treatment of myelodysp...

Apr 4, 2025  0

Clinical Trials Information System

Clinical Trials Information System

Feb 24, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - March 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 March 2025, 11:00 (CET) to 25 March 2025, 12:00 (CET)

Questions and answers clinic on Product Management Serv...

Mar 7, 2025  0